According to estimates, Dubai’s pharma market is projected to grow by 9.6 per cent to USD 25.6 billion (AED 94 billion) by 2022, depicting a profitable opportunity to the pharma companies worldwide.
Dubai’s growing population, technological advancements and central geographical location are sure to lend a helping hand in increasing the value of the GCC and MEA pharmaceutical markets in the upcoming years.
Visit for more details: https://www.delveinsight.com/blog/dubai-a-leading-and-exciting-pharma-hotspot/